According to CinCor Pharma's latest financial reports the company has $0.52 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2021-12-31 | $0.13 B | 423.83% |
2020-12-31 | $26.07 M | 127.08% |
2019-12-31 | $11.48 M |